Cerebrospinal Fluid Management Market

Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022

Report Code: MD 6284 May, 2018, by marketsandmarkets.com

[120 Pages Report] The global cerebrospinal fluid management market was valued at USD 1.20 Billion in 2016 and is projected to reach USD 1.56 Billion by 2022, at a CAGR of 4.4%. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022.

Objectives of the Study

  • To define, describe, and forecast the global cerebrospinal fluid management market by product, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast size of market segments in North America, Europe, Asia Pacific, and RoW2
  • To analyze the market structure and profile key players of the global CSF management market and comprehensively analyze their core competencies3
  • To analyze the competitive landscape of the major players operating in the CSF management market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global cerebrospinal fluid management market and estimate the size of other dependent submarkets. Various secondary sources such as Food and Drug Administration (FDA), Hydrocephalus Association, World Health Organization (WHO), National Hydrocephalus Foundation (NHF), Pediatric Hydrocephalus Foundation (PHF), International Federation for Spina Bifida and Hydrocephalus (IFSBH), Hydrocephalus Clinical Research Network, Pacific Adult Hydrocephalus Center, Press Releases, Directories, Industry journals, Databases, and Annual Reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Cerebrospinal Fluid (CSF) Management Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the global cerebrospinal fluid management market are Medtronic plc (Ireland), Integra LifeSciences Holdings Corporation (US), B. Braun Melsungen AG (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).

Target Audience:

  • CSF management and related device manufacturers
  • Suppliers and distributors of CSF management devices
  • Hospitals, diagnostic centers, home care service providers, and medical colleges
  • Teaching hospitals and academic medical centers
  • Government bodies and municipal corporations
  • Business research and consulting service providers
  • Venture capitalists

Scope of the Report:

The research report categorizes the cerebrospinal fluid management market into the following segments and subsegments:

Cerebrospinal Fluid Management Market, by Product

  • Shunts
    • By Shunt Type
      • Ventriculoperitoneal (VP)
      • Ventriculoatrial (VA)
      • Lumboperitoneal (LP)
      • Ventriculopleural (VPL)
    • By Valve Type
      • Fixed
      • Adjustable
  • External Drainage Systems
    • External Ventricular Drainage (EVD) Systems
    • Lumbar Drainage (LD) Systems

Cerebrospinal Fluid Management Market, by End User

  • Pediatric
  • Adult
  • Geriatric

Cerebrospinal Fluid Management Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

  • Detailed analysis and profiling of additional market players (up to 3)

Shunts segment to grow at the highest CAGR during the forecast period

On the basis of product, the global cerebrospinal fluid (CSF) management market, is segmented into shunts and external drainage systems. In 2017, the shunts segment is expected to account for the largest share of the global cerebrospinal fluid (CSF) management market. The shunts market is further segmented into ventriculoperitoneal (VP), ventriculoatrial (VA), ventriculopleural (VPL), and lumboperitoneal (LP) shunts. Over the years, the disease burden of hydrocephalus has increased considerably, increasing the demand for CSF management devices as a method of treatment. Cerebrospinal fluid (CSF) management involves the use of devices such as shunts and external drainage systems to maintain the flow of CSF and drain excess fluid from the brain.

The cerebrospinal fluid (CSF) management market is projected to reach USD 1,561.1 million by 2022. Factors such as the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population are driving the growth of the CSF management market.

Dearth of trained professionals and complications related to CSF shunts are challenging market growth to a certain extent.

There is a significant shortage of neurophysicians and neurosurgeons worldwide. With the rapidly increasing aging population, the current number of neurosurgeons is inadequate to meet the healthcare demand. One of the greatest limitations is the inability to produce a sufficient number of trained neurosurgeons in the required amount of time. This shortage of trained professionals in neurosurgery extends to North America, Europe, Asia Pacific, Latin America, and Africa.

Hydrocephalus can be treated with a shunt system; however, this treatment often includes complications. The most common shunt complications include malfunction, infection, and shunt obstruction. According to Pediatric Emergency Medicine Reports, about 40% of shunts fail within the first year and 56–80% by 10 years. Additionally, between 8–10% of shunts eventually become infected. Shunt malfunction can lead to an acute increase in intracranial pressure (ICP), causing irreparable impairment of the brain.

However, developing economies such as Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world with a large patient base of hydrocephalus. The presence of such a huge patient base in this region, along with rising healthcare expenditure, is expected to serve as an opportunity for players in the CSF management market.

Market Dynamics

Cerebrospinal Fluid (CSF) Management Market

VP shunts are superior to other shunts as they reduce the chances of revision surgery and the average length of hospital stay.

Ventriculoperitoneal (VP) shunts

VP shunts are the most common type of shunts for draining excess CSF. These shunts generally contain a pressure-sensitive valve that releases CSF when the pressure reaches a certain level. In VP shunts, a catheter is inserted into the ventricle with tubing passing subcutaneously through the thorax, into the peritoneal cavity where the CSF absorption takes place. Over the years, VP shunts have been found to be superior to other shunts as they reduce the chances of revision surgery and the average length of hospital stay.

Ventriculoatrial (VA) shunts

VA shunts are less common than VP shunts. These shunts enable CSF to flow from the cerebral ventricular system to the atrium of the heart. In some patients, the peritoneal space is inadequate, necessitating the use of an alternative distal site for CSF drainage. Common reasons for peritoneal inadequacy include intra-abdominal infection and scarring due to prior procedures or intra-abdominal pathology. Additionally, VA shunts are used in patients who already have VP shunts implanted but require further drainage to achieve symptom relief.

Lumboperitoneal (LP) shunts

An LP shunt diverts CSF from the spinal space in the lumbar region to the abdominal space. It is used to treat non-obstructive hydrocephalus, normal pressure hydrocephalus, elevated intracranial pressure, and idiopathic intracranial hypertension. An LP shunt consists of a catheter inserted between two lumbar vertebras into the thecal space, which is then tunneled around the abdomen into the peritoneal cavity for absorption. The adoption of these shunts is low as they are associated with a greater likelihood of shunt revision, increased hospital stay, and greater overall charges to the healthcare system.

Ventriculopleural (VPL) shunts

VPL shunts are safe and viable second-line CSF shunts for cases in which ventriculoperitoneal and ventriculoatrial shunts are unsuitable. While VPL shunts have a high revision rate, their complication rate is comparable to that of VP shunts. VPL shunt survival can be improved by careful patient selection and the implementation of a combination of valves with anti-siphon devices.

High prevalence and incidence of hydrocephalus along with rising number of shunting procedures are driving the growth of CSF management market in pediatric population

Pediatric End Users

According to the Hydrocephalus Association, one in 500 children is affected worldwide, and one to two of every 1,000 babies is born with hydrocephalus. This is estimated to contribute to over 200,000 cases each year of congenital hydrocephalus in infants around the world. Moreover, children can acquire hydrocephalus after birth due to brain hemorrhage, infection, tumors, trauma, or parasites, thereby increasing the total number of pediatric patients with hydrocephalus. This rising prevalence of hydrocephalus has led to an increase in shunting procedures. The high prevalence and incidence of hydrocephalus in the pediatric population, along with the rising number of shunting procedures, is expected to drive this market segment.

Adult End Users

While hydrocephalus is considered common in infants and the elderly, its occurrence in adults is also rising. Hydrocephalus also goes undiagnosed and untreated in younger adults, leading to substantial workforce losses and healthcare costs. SHYMA (syndrome of hydrocephalus in young and middle-aged adults) is a type of hydrocephalus that affects the adult population. However, this type of hydrocephalus is complicated; not much is known about the disease or its causes. Moreover, there are two other forms of hydrocephalus that affect adults hydrocephalus ex vacuo and normal pressure hydrocephalus. However, according to the Hydrocephalus Association, there are fewer than ten centers in the US specializing in treating adults with hydrocephalus.

Geriatric End Users

According to the Hydrocephalus Association, over 700,000 older Americans are living with NPH. Moreover, one in every 1,000 senior citizens in the US develops NPH each year.

This is further expected to rise with the increasing global geriatric population worldwide, to reach 1.57 billion in 2050 from 617.1 million in 2015 (Source: US Census Bureau). Furthermore, with the rising adoption of CSF management devices, the treatment for elderly patients has become easier. Thus, the rising cases of hydrocephalus in the geriatric population, along with the high success rate of surgical procedures in resolving NPH symptoms, are expected to aid the market growth of this end-user segment

Key Questions

  • Which regions will provide the high growth opportunities
  • Who are the major end users and what are the transitions expected in the usage of various type of shunts in coming years
  • Who are the key players an dWhat are the factors driving and restraining the market

The global cerebrospinal fluid management market is projected to reach USD 1.56 Billion by 2022 from an estimated USD 1.26 Billion in 2017, at a CAGR of 4.4% during the forecast period. The growth of this market is majorly driven by factors such as the growing geriatric population and the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures.

The cerebrospinal fluid management market is segmented by product, end user, and region. Based on product, the market is segmented into shunts and external drainage systems. The shunts market is expected to grow at the highest CAGR during the forecast period. The high growth in the shunts market can be primarily attributed to the growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries. Based on the type, the shunts segment is further segmented into ventriculoperitoneal (VP), ventriculoatrial (VA), lumboperitoneal (LP), and ventriculopleural (VPL). The external drainage systems segment is further segmented on basis of type into external ventricular drainage and lumbar drainage.

Based on end user, the global cerebrospinal fluid management market is categorized into pediatric, adult, and geriatric. The pediatric segment is expected to register the highest CAGR during the forecast period. This can primarily be attributed to the high prevalence of congenital hydrocephalus along with the rising number of shunting procedures in the pediatric population.

Geographic segments in cerebrospinal fluid management market report include North America, Europe, Asia Pacific, and the RoW. North America accounted for the largest share of the market in 2017. The large share of this region can primarily be attributed to the rising prevalence of hydrocephalus, increasing funding for hydrocephalus research in the US, and the launch of organizations such as Hydrocephalus Canada.

Cerebrospinal Fluid (CSF) Management Market

The dearth of trained professionals and complications related to CSF shunts may challenge market growth to a certain extent during the forecast period. For instance, in South Africa, there were 0.061 neurosurgeons per 100,000 people in 2016. This unavailability of medical professionals in developing countries is likely to reduce the chances of diagnosis and treatment of conditions requiring CSF management.

The major players in cerebrospinal fluid Management market include Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Cerebrospinal Fluid Management Market: Introduction (Page No. - 12)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Cerebrospinal Fluid Management Market: Research Methodology (Page No. - 15)
    2.1 Research Design
    2.2 Research Approach
           2.2.1 Secondary Research
                    2.2.1.1 Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Primary Sources
    2.3 Market Size Estimation Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Cerebrospinal Fluid Management Market: Executive Summary (Page No. - 24)

4 Premium Insights (Page No. - 29)
    4.1 Global Cerebrospinal Fluid Management Market: Market Overview
    4.2 Cerebrospinal Fluid Management Market, By End User and Region
    4.3 Geographic Snapshot: Cerebrospinal Fluid Management Market
    4.4 Cerebrospinal Fluid Management Market, By Product

5 Market Overview (Page No. - 33)
    5.1 Introduction
           5.1.1 Drivers
                    5.1.1.1 High Prevalence of Hydrocephalus and the Subsequent Increase in the Number of Shunting Procedures
                    5.1.1.2 Growing Geriatric Population
           5.1.2 Opportunities
                    5.1.2.1 Growing Healthcare Market in Developing Economies
           5.1.3 Challenges
                    5.1.3.1 Dearth of Trained Professionals
                    5.1.3.2 Complications Related to CSF Shunts

6 Cerebrospinal Fluid Management Market, By Product (Page No. - 38)
    6.1 Introduction
    6.2 Shunts
           6.2.1 Shunts Market, By Type
                    6.2.1.1 Ventriculoperitoneal (VP) Shunts
                    6.2.1.2 Ventriculoatrial (VA) Shunts
                    6.2.1.3 Lumboperitoneal (LP) Shunts
                    6.2.1.4 Ventriculopleural (VPL) Shunts
           6.2.2 Shunts Market, By Valve Type
                    6.2.2.1 Fixed Valve Shunts
                    6.2.2.2 Adjustable Valve Shunts
    6.3 External Drainage Systems
           6.3.1 External Ventricular Drainage (EVD) Systems
           6.3.2 Lumbar Drainage (LD) Systems

7 Cerebrospinal Fluid Management Market, By End User (Page No. - 48)
    7.1 Introduction
    7.2 Pediatric End Users
    7.3 Adult End Users
    7.4 Geriatric End Users

8 Cerebrospinal Fluid Management Market, By Region (Page No. - 53)
    8.1 Introduction
    8.2 North America
           8.2.1 Us
           8.2.2 Canada
    8.3 Europe
           8.3.1 EU5
           8.3.2 RoE
    8.4 Asia Pacific
           8.4.1 Japan
           8.4.2 China
           8.4.3 India
           8.4.4 Rest of Asia Pacific
    8.5 Rest of the World

9 Market Share Analysis (Page No. - 90)
    9.1 Introduction
           9.1.1 Medtronic
           9.1.2 Depuy Synthes
           9.1.3 B.Braun
           9.1.4 Integra
           9.1.5 Other Players

10 Company Profiles (Page No. - 92)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     10.1 Medtronic
     10.2 Integra Lifesciences Holdings Corporation
     10.3 B. Braun Melsungen
     10.4 Spiegelberg GmbH & Co. Kg
     10.5 SOPHYSA (A Subsidiary of TKB Group)
     10.6 Natus Medical Incorporated
     10.7 Dispomedica GmbH
     10.8 Deltasurgical
     10.9 Argi Grup
     10.10 Moller Medical GmbH
     10.11 G.SURGIWEAR LTD 
     10.12 Wellong Instruments Co., Ltd

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. - 112)
     11.1 Discussion Guide
     11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     11.3 Introducing RT: Real-Time Market Intelligence
             11.3.1 Features and Benefits of RT :
     11.4 Available Customizations
     11.5 Related Reports
     11.6 Author Details


List of Tables (92 Tables)

Table 1 Prevalence of Congenital Hydrocephalus, 2012
Table 2 Population Aged 60 and Above, By Region, 2017
Table 3 Neurosurgery Workforce in Major Countries, 2016
Table 4 CSF Management Market, By Product, 2015–2022 (USD Million)
Table 5 CSF Management Shunts Market, By Region, 2015–2022 (USD Million)
Table 6 Differences Between the Types of CHF Shunts Available in the Market
Table 7 CSF Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 8 Ventriculoperitoneal Shunts Market, By Region, 2015–2022 (USD Million)
Table 9 Ventriculoatrial Shunts Market, By Region, 2015–2022 (USD Million)
Table 10 Lumboperitoneal Shunts Market, By Region, 2015–2022 (USD Million)
Table 11 Ventriculopleural Shunts Market, By Region, 2015–2022 (USD Million)
Table 12 CSF Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 13 Fixed Valve Shunts Market, By Region, 2015–2022 (USD Million)
Table 14 Adjustable Valve Shunts Market, By Region, 2015–2022 (USD Million)
Table 15 Differences Between External Ventricular Drainage and Lumbar Drainage Systems
Table 16 CSF Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 17 CSF Management External Drainage Systems Market, By Region, 2015–2022 (USD Million)
Table 18 External Ventricular Drainage Systems Market, By Region, 2015–2022 (USD Million)
Table 19 Lumbar Drainage Systems Market, By Region, 2015–2022 (USD Million)
Table 20 CSF Management Market, By End User, 2015–2022 (USD Million)
Table 21 Pediatric CSF Management Market, By Region, 2015–2022 (USD Million)
Table 22 Adult CSF Management Market, By Region, 2015–2022 (USD Million)
Table 23 Geriatric CSF Management Market, By Region, 2015–2022 (USD Million)
Table 24 CSF Management Market, By Region, 2015–2022 (USD Million)
Table 25 North America: Cerebrospinal Fluid Management Market, By Country, 2015–2022 (USD Million)
Table 26 North America: Cerebrospinal Fluid Management Market, By Product, 2015–2022 (USD Million)
Table 27 North America: Cerebrospinal Fluid Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 28 North America: Cerebrospinal Fluid Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 29 North America: Cerebrospinal Fluid Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 30 North America: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
Table 31 Hydrocephalus Research Projects in the Us, 2014–2018
Table 32 US: Cerebrospinal Fluid Management Market, By Product, 2015–2022 (USD Million)
Table 33 US: Cerebrospinal Fluid Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 34 US: Cerebrospinal Fluid Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 35 US: Cerebrospinal Fluid Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 36 US: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
Table 37 Hydrocephalus Canada: Funds Raised and Program Spending, 2016
Table 38 Canada: Cerebrospinal Fluid Management Market, By Product, 2015–2022 (USD Million)
Table 39 Canada: Cerebrospinal Fluid Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 40 Canada: Cerebrospinal Fluid Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 41 Canada: Cerebrospinal Fluid Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 42 Canada: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
Table 43 Europe: Cerebrospinal Fluid Management Market, By Region, 2015–2022 (USD Million)
Table 44 Europe: Cerebrospinal Fluid Management Market, By Product, 2015–2022 (USD Million)
Table 45 Europe: Cerebrospinal Fluid Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 46 Europe: Cerebrospinal Fluid Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 47 Europe: Cerebrospinal Fluid Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 48 Europe: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
Table 49 Shunting Procedures in the UK, 2010–2014
Table 50 EU5: Cerebrospinal Fluid Management Market, By Product, 2015–2022 (USD Million)
Table 51 EU5: Cerebrospinal Fluid Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 52 EU5: Cerebrospinal Fluid Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 53 EU5: Cerebrospinal Fluid Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 54 EU5: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
Table 55 Geriatric Population in RoE Countries (As A Percentage of the Total Population)
Table 56 RoE: CSF Management Market, By Product, 2015–2022 (USD Million)
Table 57 RoE: CSF Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 58 RoE: CSF Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 59 RoE: CSF Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 60 RoE: CSF Management Market, By End User, 2015–2022 (USD Million)
Table 61 Asia Pacific: CSF Management Market, By Country, 2015–2022 (USD Million)
Table 62 Asia Pacific: CSF Management Market, By Product, 2015–2022 (USD Million)
Table 63 Asia Pacific: CSF Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 64 Asia Pacific: CSF Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 65 Asia Pacific: CSF Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 66 Asia Pacific: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
Table 67 Japan: Cerebrospinal Fluid Management Market, By Product, 2015–2022 (USD Million)
Table 68 Japan: CSF Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 69 Japan: CSF Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 70 Japan: CSF Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 71 Japan: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
Table 72 China: Cerebrospinal Fluid Management Market, By Product, 2015–2022 (USD Million)
Table 73 China: CSF Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 74 China: CSF Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 75 China: CSF Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 76 China: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
Table 77 India: Cerebrospinal Fluid Management Market, By Product, 2015–2022 (USD Million)
Table 78 India: CSF Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 79 India: CSF Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 80 India: CSF Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 81 India: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
Table 82 RoAPAC: Cerebrospinal Fluid Management Market, By Product, 2015–2022 (USD Million)
Table 83 RoAPAC: CSF Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 84 RoAPAC: CSF Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 85 RoAPAC: CSF Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 86 RoAPAC: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
Table 87 Middle East & Latin America: Population Aged 65 Years & Above (% of the Total Population)
Table 88 RoW: Cerebrospinal Fluid Management Market, By Product, 2015–2022 (USD Million)
Table 89 RoW: CSF Management Shunts Market, By Type, 2015–2022 (USD Million)
Table 90 RoW: CSF Management Shunts Market, By Valve Type, 2015–2022 (USD Million)
Table 91 RoW: CSF Management External Drainage Systems Market, By Type, 2015–2022 (USD Million)
Table 92 RoW: Cerebrospinal Fluid Management Market, By End User, 2015–2022 (USD Million)
 
 
List of Figures (31 Figures)
 
Figure 1 Research Design: CSF Management Market
Figure 2 CSF Management Market: Research Methodology Steps
Figure 3 Sampling Frame: Primary Research
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Key Industry Insights
Figure 6 Market Size Estimation Methodology: Bottom-Up Approach
Figure 7 Market Size Estimation Methodology: Top-Down Approach
Figure 8 Data Triangulation Methodology
Figure 9 Shunts to Dominate the Cerebrospinal Fluid Management Market in 2017
Figure 10 Ventriculoperitoneal Segment Dominated the CSF Shunts Market in 2017
Figure 11 Adjustable Valve Shunts Accounted for the Largest Share of the CSF Shunts Market in 2017
Figure 12 External Ventricular Drainage to Command the Largest Share of External Drainage Systems Market in 2017
Figure 13 Pediatric End-User Segment Dominated the Cerebrospinal Fluid Management Market in 2017
Figure 14 Asia Pacific to Witness the Highest Market Growth During the Forecast Period
Figure 15 Increasing Prevalence of Hydrocephalus and Growing Geriatric Population are Driving Market Growth
Figure 16 Pediatric End-User Segment Dominated the Cerebrospinal Fluid Management Market in 2017
Figure 17 Asia Pacific to Witness the Highest Growth During the Forecast Period
Figure 18 Shunts Commanded the Largest Market Share in 2017
Figure 19 Cerebrospinal Fluid Management Market: Drivers, Opportunities, and Challenges
Figure 20 Shunts Dominated the Cerebrospinal Fluid Management Market in 2017
Figure 21 Pediatric End Users to Dominate the Cerebrospinal Fluid Management Market in 2017
Figure 22 North America to Command the Largest Share of the Market in 2017
Figure 23 North America: Cerebrospinal Fluid Management Market Snapshot
Figure 24 Europe: Cerebrospinal Fluid Management Market Snapshot
Figure 25 Asia Pacific: Cerebrospinal Fluid Management Market Snapshot
Figure 26 RoW: CSF Management Market Snapshot
Figure 27 Value-Based Market Shares of Key Players, 2016
Figure 28 Medtronic: Company Snapshot (2016)
Figure 29 Integra Lifesciences Holdings Corporation: Company Snapshot (2017)
Figure 30 B. Braun Melsungen: Company Snapshot (2017)
Figure 31 Natus Medical Incorporated: Company Snapshot (2017)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 6284
Published ON
May, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cerebrospinal Fluid Management Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved